Interview With Dr. J. Thomas Parmeter, President & CEO,
Available Via Protein Polymer's Web Site
SAN DIEGO, Jan. 12 /PRNewswire-FirstCall/ -- Protein Polymer Technologies
(OTC Bulletin Board: PPTI), a Company focused on the development of high
performance bioactive devices designed for improved surgical outcomes,
announced today that its president and CEO, Dr. J. Thomas Parmeter, was a
recent featured guest on the Health & Beauty Revolution Show. A replay of the
interview can now be accessed via PPTI's recently updated web site
( http://www.ppti.com ).
During the online radio broadcast, Dr. Parmeter, in addition to describing
PPTI's development of its product for dermal contour corrections, discussed
the multiple applications for the PPTI's self-assembling hydrogel and
chemically cross-linked adhesive technologies. Specific highlights include:
* PPTI overview including two products in human clinicals, a third
expected to begin human clinicals in the next two months, new products
in the pipeline, all based on technology covered by 25 U.S. Patents
* Detailed explanation of PPTI's injectable dermal contouring product,
how the injectable hydrogel is applied and contoured, and why its
properties should meet the market need
* Why PPTI's dermal augmentation technology, as compared to similar
cosmetic techniques, may prove to be more effective
* Discussion of the dermal clinical protocol and estimated FDA approval
in 24 months
* Benefits of PPTI's technology for treating female stress urinary
incontinence and damaged spinal discs.
"The cosmetic application industry represents a large potential market for
our technology, and the Health & Beauty Revolution Show offered an excellent
forum to educate this key audience about our injectable dermal augmentation
product, as well as our products for female urinary stress incontinence and
spinal disc repair," stated J. Thomas Parameter, Ph.D., President and CEO of
Protein Polymer Technologies. "As Protein Polymer solidifies business
relationships, such as the renewed agreement with Spine Wave, Inc., and as our
technologies move closer to FDA approval, we will continue to utilize media
and investor opportunities to showcase the growth and progress of our
company."
The Health & Beauty Revolution Show is broadcast every Monday at
11:00 A.M., PT via wsRadio.com ( http://www.wsradio.com ), largest independent
Internet radio station in the world.
About Protein Polymer Technologies
Protein Polymer Technologies, Inc., is a San Diego-based company focused
on developing bioactive devices to improve medical and surgical outcomes.
From its inception in 1988, PPTI has been a pioneer in protein design and
synthesis, creating an extensive portfolio of proprietary biomaterials for use
in the development of bioactive devices. These genetically engineered
biomaterials are high molecular weight proteins, processed into products with
physical and biological characteristics tailored to specific clinical
performance requirements. Targeted products include urethral bulking agents
for the treatment of stress urinary incontinence, dermal augmentation products
for cosmetic and reconstructive surgery, surgical adhesives and sealants,
scaffolds for wound healing and tissue engineering, and depots for local drug
delivery. To date, PPTI has been issued twenty-five U.S. Patents on its core
technology with corresponding issued and pending patents in key international
markets.
Safe Harbor
This press release contains forward-looking statements that are based on
management's views and expectations. Actual results could differ materially
from those expressed here; further, the Company is not obligated to comment
specifically on those differences. Risks associated with the Company's
activities include raising adequate capital to continue operations scientific
and product development uncertainties, competitive products and approaches,
continuing collaborative partnership interest and funding, regulatory testing
and approvals, and manufacturing scale up. The reader is encouraged to refer
to the Company's 2002 Annual Report Form 10-KSB, and other recent filings with
the Securities and Exchange Commission, copies of which are available from the
Company, to further ascertain the risks associated with the above statements.
SOURCE Protein Polymer Technologies
 back to top
Related links:
http://www.ppti.com
CONTACT:
J. Thomas Parmeter, Ph.D., President, Chief
Executive Officer of Protein Polymer Technologies,
+1-858-558-6064; or investors, Jill Meleski, Assistant Vice
President of The Ruth Group, +1-646-536-7032, for Protein Polymer
Technologies
|
